Precision Neuroscience

Precision Neuroscience is a neurotechnology company founded in 2021 that specializes in developing minimally invasive brain-computer interfaces (BCIs) aimed at treating neurological disorders. The company focuses on high-resolution, non-penetrating cortical surface arrays that record brain signals without damaging tissue. Its flagship product, the Layer 7 Cortical Interface, is a thin-film microelectrode array designed to capture detailed brain activity, enabling thought-controlled actions. Co-founded by neurosurgeon Ben Rapoport and business builder Michael Mager, Precision Neuroscience has expanded its team and established its own manufacturing facility. The company has conducted human clinical trials and received FDA clearance for its core device, with commercial products expected soon. Precision's mission is to create safe, removable BCIs that enhance communication and independence for individuals with severe conditions such as paralysis and speech deficits. The company collaborates with notable institutions like the Rockefeller Neuroscience Institute and Mount Sinai Health System to advance its clinical development efforts.